U.S. flag

An official website of the United States government

NM_000492.4(CFTR):c.1546A>G (p.Arg516Gly) AND not specified

Germline classification:
Uncertain significance (1 submission)
Last evaluated:
Aug 7, 2023
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV003331194.1

Allele description [Variation Report for NM_000492.4(CFTR):c.1546A>G (p.Arg516Gly)]

NM_000492.4(CFTR):c.1546A>G (p.Arg516Gly)

Genes:
CFTR:CF transmembrane conductance regulator [Gene - OMIM - HGNC]
CFTR-AS1:CFTR antisense RNA 1 [Gene - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
7q31.2
Genomic location:
Preferred name:
NM_000492.4(CFTR):c.1546A>G (p.Arg516Gly)
HGVS:
  • NC_000007.14:g.117559617A>G
  • NG_016465.4:g.98834A>G
  • NM_000492.4:c.1546A>GMANE SELECT
  • NP_000483.3:p.Arg516Gly
  • NP_000483.3:p.Arg516Gly
  • LRG_663t1:c.1546A>G
  • LRG_663:g.98834A>G
  • LRG_663p1:p.Arg516Gly
  • NC_000007.13:g.117199671A>G
  • NM_000492.3:c.1546A>G
Protein change:
R516G
Links:
dbSNP: rs397508226
NCBI 1000 Genomes Browser:
rs397508226
Molecular consequence:
  • NM_000492.4:c.1546A>G - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Synonyms:
AllHighlyPenetrant
Identifiers:
MedGen: CN169374

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV004038290Women's Health and Genetics/Laboratory Corporation of America, LabCorp
criteria provided, single submitter

(LabCorp Variant Classification Summary - May 2015)
Uncertain significance
(Aug 7, 2023)
germlineclinical testing

PubMed (2)
[See all records that cite these PMIDs]

Citation Link

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Complete CFTR gene sequencing in 5,058 individuals with cystic fibrosis informs variant-specific treatment.

Raraigh KS, Aksit MA, Hetrick K, Pace RG, Ling H, O'Neal W, Blue E, Zhou YH, Bamshad MJ, Blackman SM, Gibson RL, Knowles MR, Cutting GR.

J Cyst Fibros. 2022 May;21(3):463-470. doi: 10.1016/j.jcf.2021.10.011. Epub 2021 Nov 12.

PubMed [citation]
PMID:
34782259

Image-based β-adrenergic sweat rate assay captures minimal cystic fibrosis transmembrane conductance regulator function.

Salinas DB, Peng YH, Horwich B, Wee CP, Frisbee E, Maarek JM.

Pediatr Res. 2020 Jan;87(1):137-145. doi: 10.1038/s41390-019-0503-8. Epub 2019 Jul 25.

PubMed [citation]
PMID:
31344706
PMCID:
PMC6962560

Details of each submission

From Women's Health and Genetics/Laboratory Corporation of America, LabCorp, SCV004038290.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (2)

Description

Variant summary: CFTR c.1546A>G (p.Arg516Gly) results in a non-conservative amino acid change located in the ABC transporter-like, ATP-binding domain (IPR003439) of the encoded protein sequence. Five of five in-silico tools predict a damaging effect of the variant on protein function. The variant was absent in 251194 control chromosomes (gnomAD). The available data on variant occurrences in the general population are insufficient to allow any conclusion about variant significance. c.1546A>G has been reported in the literature in individuals affected with Cystic Fibrosis (examples: Salinas_2020, http://www.genet.sickkids.on.ca/). These data do not allow any conclusion about variant significance. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. The following publications have been ascertained in the context of this evaluation (PMID: 34782259, 31344706). Two submitters have cited clinical-significance assessments for this variant to ClinVar after 2014. One submitter classified the variant as likely pathogenic, and one submitter classified the variant as uncertain significance. Based on the evidence outlined above, the variant was classified as uncertain significance.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: May 1, 2024